BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/31/2021 6:51:26 AM | Browse: 306 | Download: 264
 |
Received |
|
2021-05-06 11:56 |
|
Peer-Review Started |
|
2021-05-06 11:59 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-06-06 16:23 |
|
Revised |
|
2021-06-16 10:48 |
|
Second Decision |
|
2021-07-02 13:09 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-07-02 13:38 |
|
Articles in Press |
|
2021-07-02 13:38 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-07-14 23:20 |
|
Typeset the Manuscript |
|
2021-08-24 04:51 |
|
Publish the Manuscript Online |
|
2021-08-31 06:51 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Case Report |
| Article Title |
Hemorrhagic pericardial effusion following treatment with infliximab: A case report and review of literature
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Hui Li, Hui Xing, Chen Hu, Bai-Yang Sun, Shuang Wang, Wan-Ying Li and Bo Qu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Bo Qu, MD, PhD, Chief Doctor, Professor, Department of Gastroenterology, The 2nd Affiliated Hospital of Harbin Medical University, No. 246 Xuefu Road, Harbin 150086, Heilongjiang Province, China. qubo_1970@hotmail.com |
| Key Words |
Hemorrhagic pericardial effusion; Pericardial complication; Infliximab; Crohn's disease; Anti-tumor necrosis factor alpha; Case report |
| Core Tip |
Pericarditis or pericardial effusion is a rare but serious complication of infliximab (IFX), especially cardiac tamponade, and most of the patients have rheumatoid arthritis and drug-induced lupus erythematosus. This is a case of hemorrhagic pericardial effusion following treatment with IFX. The patient was diagnosed with Crohn's disease. A high titer of anti-IFX antibodies and a strong type III immunologic reaction may be a possible cause. This suggests that clinicians need to pay attention to the occurrence of pericardial effusion in patients treated with IFX. Early recognition helps prevent the occurrence of hemorrhagic pericardial effusion and minimize its impact on the natural evolution of the disease. |
| Publish Date |
2021-08-31 06:51 |
| Citation |
Li H, Xing H, Hu C, Sun BY, Wang S, Li WY, Qu B. Hemorrhagic pericardial effusion following treatment with infliximab: A case report and review of literature. World J Clin Cases 2021; 9(25): 7593-7599 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i25/7593.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i25.7593 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
